Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidoglycan crosslinking enzymes are essential bacterial enzymes responsible for forming the covalent bonds that link peptidoglycan (PG) strands together, creating a rigid and protective cell wall structure. These enzymes are crucial for bacterial survival, as they provide mechanical strength to withstand internal osmotic pressure and maintain cell shape. There are two main classes: D,D-Transpeptidases (Penicillin-Binding Proteins, PBPs) and L,D-Transpeptidases (Ldts). PBPs catalyze 4-3 peptide crosslinks and are primary targets for β-lactam antibiotics. Ldts catalyze alternative crosslinks and are especially important under antibiotic stress. Inhibition of these enzymes leads to weakened cell walls and cell death, exploited by many antibiotics. Resistance mechanisms include altered enzyme specificity or expression levels.
Inhibition of peptidoglycan crosslinking, leading to cell wall weakening and lysis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan Crosslinking Enzyme.